Karmanos Cancer Institute offers new cellular therapy for lymphoma – Southgate News Herald
|
Karmanos Cancer Institute offers new cellular therapy for lymphoma
Southgate News Herald CAR-T chimeric antigen receptor T cell therapy — is new a type of immunotherapy — born out of years of cellular therapy research. The Michigan doctors working in this new field are Joseph Uberti, Karmanos' division chief of hematology and co-director … |
